Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | GFER | P55789 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | FCGR3B | O75015 | 1/20 | 0.46 |
| ▸ | FCGR1A | P12314 | 1/20 | 0.46 |
| ▸ | FCGR2A | P12318 | 1/20 | 0.46 |
| ▸ | CRHR1 | P34998 | 4/20 | 0.44 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | XBP1 | P17861 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | IDH2 | P48735 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30562898 | 1.00 | MAPT (0.49) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL25381533 | 0.87 | BCL6 (0.46) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL14118021 | 0.85 | KCNH3 (0.46) | MAPTMEN1GAAKMT2AKDM4E | |
| SCHEMBL31149854 | 0.82 | CFTR (0.53) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL16010929 | 0.82 | CFTR (0.53) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL30562985 | 0.81 | MEN1 (0.74) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL14236870 | 0.81 | MEN1 (0.74) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL13921801 | 0.80 | KCNH3 (0.69) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL30562940 | 0.80 | KCNH3 (0.69) | MAPTMEN1GAAKMT2ALMNA | |
| SCHEMBL13917172 | 0.80 | KCNH3 (0.69) | MAPTMEN1GAAKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250163218-A1 | POLYIMIDE PRECURSOR FOR DISPLAY SUBSTRATE, POLYIMIDE FILM FOR DISPLAY SUBSTRATE, AND DISPLAY SUBSTRATE | UBE CORPORATION (JP) | 2025-05-22 | — | — | US | disclosed |
| US-10174166-B2 | Polyimide precursor, polyimide, varnish, polyimide film, and substrate | UBE INDUSTRIES, LTD. (JP) | 2019-01-08 | — | — | US | disclosed |
| US-9511565-B2 | Polyimide precursor, polyimide, polyimide film, and method for manufacturing triazine compound used for manufacturing same | UBE INDUSTRIES, LTD. (JP) | 2016-12-06 | — | — | US | disclosed |
| US-20150361222-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, VARNISH, POLYIMIDE FILM, AND SUBSTRATE | UBE CORPORATION (JP) | 2015-12-17 | — | — | US | disclosed |
| US-20140255710-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, POLYIMIDE FILM, AND METHOD FOR MANUFACTURING TRIAZINE COMPOUND USED FOR MANUFACTURING SAME | NATIONAL UNIVERSITY CORPORATION IWATE UNIVERSITY (JP) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140255710-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, POLYIMIDE FILM, AND METHOD FOR MANUFACTURING TRIAZINE COMPOUND USED FOR MANUFACTURING SAME | F12, TERB1, PBRM1 | MAPT 347/4885MEN1 601/4885GAA 3468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.